Affymax

Affymax FCF/Debt

The Free Cash Flow to Debt Ratio of Affymax (AFFY) as of Nov 2, 2026 is -712.43 %. In the previous year, Free Cash Flow to Debt Ratio was -26.70 % — a change of 2,567.88% (lower).

FCF/Debt

-712.43 %

YoY

2,567.88%

Last updated:

Free Cash Flow to Debt Ratio of Affymax is 2013 -712.43 % . Free Cash Flow to Debt Ratio of Affymax was 2012 -26.70 % . It decreases by 2,567.88% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Affymax Stock analysis

What does Affymax do? Affymax Inc is a leading biotechnology company specializing in the development of innovative therapeutics for patients with serious diseases. The company was founded in 2001 and is headquartered in Palo Alto, California. Affymax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Affymax stock

Free Cash Flow to Debt Ratio of Affymax is -712.43 % in 2013.

Free Cash Flow to Debt Ratio of Affymax changed from -26.70 % to -712.43 %, representing a 2,567.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Affymax since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Affymax with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Affymax

All Key Metrics — Affymax